Clinical Trials on Hemay005, Atopic Dermatitis in Australia
Total 217 results
-
Vyne Therapeutics Inc.CompletedAtopic DermatitisUnited States, Australia
-
Novartis PharmaceuticalsCompletedAtopic DermatitisSouth Africa, Belgium, Germany, Australia, Netherlands, Bulgaria, Austria, Romania
-
Murdoch Childrens Research InstituteSuspended
-
PfizerCompletedDermatitis, AtopicAustralia
-
Biosion, Inc.Southern Star Research Pty Ltd.CompletedAtopic DermatitisAustralia
-
Hoth Therapeutics, Inc.Novotech (Australia) Pty LimitedCompleted
-
PfizerCompletedDermatitis, AtopicAustralia, United States
-
Ribon Therapeutics, Inc.RecruitingAtopic DermatitisAustralia, New Zealand
-
RDC Clinical Pty LtdCompleted
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAtopic DermatitisPoland, United States, Australia
-
ASLAN PharmaceuticalsCompleted
-
KoBioLabsNovotech (Australia) Pty LimitedCompletedAtopic Dermatitis (AD)Australia
-
Medical University of ViennaCompleted
-
LEO PharmaCompletedAtopic DermatitisAustria
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisGermany, New Zealand, Australia
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate-to-severe Atopic DermatitisUnited States, Australia, China, New Zealand
-
Nanjing Immunophage Biotech Co., LtdNovotech (Australia) Pty LimitedNot yet recruiting
-
Stefan WoehrlMedical University of ViennaCompletedAtopic DermatitisAustria
-
Eli Lilly and CompanyIncyte CorporationCompletedAtopic DermatitisSpain, Australia, Korea, Republic of, Poland, Italy, Germany, Argentina, Austria, Japan, Taiwan
-
Medical University of ViennaCompleted
-
Eli Lilly and CompanyIncyte CorporationCompletedAtopic DermatitisSpain, Australia, Switzerland, Israel, Korea, Republic of, Japan, Poland, Argentina, Austria, Hungary
-
Technische Universität DresdenCompleted
-
Nektar TherapeuticsRecruitingModerate to Severe Atopic DermatitisSpain, Czechia, United States, Australia, Croatia, Bulgaria, Poland, Canada, Germany, Hungary
-
Astellas Pharma IncCompletedAtopic DermatitisAustralia, Belgium, Poland, Hungary, Portugal, Germany, Iceland, Malta
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
Novartis PharmaceuticalsCompletedAtopic DermatitisGermany, Austria, France
-
PfizerCompletedAtopic DermatitisUnited States, Canada, Australia, Germany, Hungary
-
Akesobio Australia Pty LtdCompletedAtopic DermatitisNew Zealand, Australia
-
Medical University of GrazCompletedPsoriasis | Atopic Eczema | Polymorphic Light EruptionAustria
-
PfizerAvailableAtopic DermatitisTaiwan, United States, Australia, Austria, Belgium, Canada, Greece, Mexico, Netherlands, Russian Federation, Spain, Switzerland
-
AnaptysBio, Inc.RecruitingAtopic Dermatitis EczemaGeorgia, United States, Australia, Canada, Czechia, New Zealand, Poland
-
AbbVieCompletedA Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic DermatitisDermatitisUnited States, Australia, Canada, Japan, Puerto Rico
-
Galderma R&DActive, not recruitingModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
-
Murdoch Childrens Research InstituteMonash UniversityCompletedDermatitis, AtopicAustralia
-
AbbVieCompletedAtopic DermatitisUnited States, Australia, Canada, Finland, Germany, Japan, Netherlands, Spain
-
Bristol-Myers SquibbCompletedDermatitis, AtopicGermany, Australia, Poland, Canada, Austria, United States, Spain
-
Eli Lilly and CompanyDermira, Inc.CompletedAtopic DermatitisUnited States, Canada, Australia, Poland
-
SanofiRegeneron PharmaceuticalsCompletedAtopic DermatitisFrance, United States, Australia, Germany, Israel, Italy, Spain, Switzerland, United Arab Emirates, United Kingdom
-
Akesobio Australia Pty LtdRecruitingPhase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic DermatitisAtopic DermatitisUnited States, Australia, New Zealand
-
MedImmune LLCAmgenCompletedAtopic DermatitisUnited States, Germany, New Zealand, Hungary, Australia, Canada
-
Hoffmann-La RocheCompletedAtopic DermatitisUnited States, Korea, Republic of, Canada, United Kingdom, Germany, Australia, Poland, Finland, France, Spain, Switzerland, Czechia, Netherlands, Taiwan
-
LEO PharmaCompletedAtopic DermatitisUnited States, Canada, Australia
-
LEO PharmaCompletedAtopic DermatitisUnited States, Denmark, United Kingdom, Korea, Republic of, Canada, Italy, Australia, Poland, Russian Federation
-
Botanix PharmaceuticalsCompletedAtopic DermatitisUnited States, Australia, New Zealand
-
SanofiRegeneron PharmaceuticalsActive, not recruitingDermatitis AtopicSpain, Czechia, Italy, Israel, Argentina, Australia, Austria, Belgium, Colombia, Finland, France, Greece, Japan, Kuwait, Mexico, Netherlands, Norway, Portugal, Russian Federation, Saudi Arabia, Taiwan, United Arab Emirates
-
AbbVieRecruitingAtopic DermatitisAustralia, Austria, Canada, Spain, Switzerland, Taiwan, United Arab Emirates, Poland, Czechia, Italy, Greece, Russian Federation, Israel, Argentina, Hungary, Mexico
-
AmgenActive, not recruitingAtopic DermatitisKorea, Republic of, United States, Turkey, Hong Kong, United Kingdom, Australia, Brazil, Canada, Argentina
-
PfizerCompletedAtopic DermatitisUnited States, Australia, Canada
-
AstraZenecaCompletedAtopic DermatitisUnited States, Germany, Australia, Spain, United Kingdom, Poland
-
Eli Lilly and CompanyIncyte CorporationCompletedAtopic DermatitisSpain, Korea, Republic of, France, Taiwan, India, Australia, Germany, Japan, Italy, Switzerland, Israel, Argentina, Austria, Czechia, Hungary, Mexico, Poland, Russian Federation, Denmark